Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current Assets
Cash	$ 1,272	$ 93
Vendor advances, net	2,859
Prepaid expenses and other current assets	38	8
Total Current Assets	4,169	101
Deferred offering costs	1,377	482
Intangible assets, net	222	382
Total Other Assets	1,599	864
TOTAL ASSETS	5,768	965
Current Liabilities
Accounts payable and accrued expenses	992	2,401
Total Current Liabilities	992	2,405
Convertible notes payable, net of debt discount of $105 at December 31, 2023		638
Total Liabilities	992	3,043
Commitments and contingencies - Notes 7 and 11
Shareholders’ Equity (Deficit)
Preferred stock, par value $0.001, 20,000,000 shares authorized; no shares issued and outstanding, respectively;
Common stock, par value $0.001, 100,000,000 shares authorized; 13,736,597 and 10,562,640 shares issued and outstanding, respectively;	14	11
Additional paid-in capital	13,577	4,123
Accumulated deficit	(8,815)	(6,212)
Total Shareholders’ Equity (Deficit)	4,776	(2,078)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)	5,768	965
Related Party [Member]
Current Liabilities
Due to related parties		$ 4